Company Filing History:
Years Active: 1998-2000
Title: Innovations by Julie A. Lippincott
Introduction
Julie A. Lippincott is a notable inventor based in Boulder, CO (US). She has made significant contributions to the field of protein engineering, particularly in the area of N-terminal methylation. With a total of 2 patents, her work has implications for the production of proteins in bacterial systems.
Latest Patents
Lippincott's latest patents focus on proteins with mutations designed to decrease N-terminal methylation. The first patent describes proteins with N-terminal modifications in their amino acid sequence that reduce or eliminate the methylation of the N-terminal methionine, which typically occurs when proteins are produced in bacteria such as E. coli. The second patent details a mutated protein that has a non-proline amino acid replacement for a proline at amino acid position 4. This mutated protein is not methylated on its N-terminus when expressed in bacteria, representing a significant advancement in protein production techniques.
Career Highlights
Julie A. Lippincott is currently associated with Somatogen, Inc., where she continues to innovate in the field of biotechnology. Her work has been instrumental in enhancing the efficiency and effectiveness of protein production, which is crucial for various applications in medicine and research.
Collaborations
Lippincott has collaborated with notable colleagues, including Jacqueline F. Aitken and Izydor Z. Apostol. These collaborations have further enriched her research and contributed to the advancement of their shared goals in protein engineering.
Conclusion
Julie A. Lippincott's contributions to the field of protein engineering through her innovative patents highlight her role as a leading inventor. Her work not only advances scientific understanding but also has practical applications in biotechnology.